Name: Mark Barton
Position: Director of Sales and Marketing
How long have you been working at MBF Bioscience?: 7.5 years
What do you do?: My responsibilities are primarily to manage all of our sales and marketing efforts. I work together with every department, and every day is something different. I work with customers to help them make the most of their research budgets when they need new equipment for their lab; I work with our software development team to help decide what new features we want to add to our products; I work with our marketing team to help find new ways for our customers to learn about our products and services; I work with our operations team to make sure new orders are processed, delivered and installed on time, and I’m here to support our sales team and make sure they have all of the most up-to-date information. I also work with the management team to plan for the future and make sure we’re all on the same page. I learn something new every day.
What are you working on right now? This past year we implemented a new CRM (customer relationship management) system and phase II will be starting in 2013 so we are planning for that. We also updated our website in 2012 and continue to add new content. We’re always looking for new products to integrate with our software and constantly testing them to make sure they meet our expectations. We’ll be adding some new hardware to our list of supported products and have some new reseller agreements so we can offer these to our customers as complete turn-key solutions.
What are some of the highlights MBF is working on for 2013? The Neuroscience Conference is the biggest event of the year for Sales and Marketing and we invested in a new booth design in 2012. We were very pleased with how well it helped us communicate with our customers at the 2012 meeting in New Orleans and now it’s time to plan for San Diego. Two products we released in the last two years, Biolucida Cloud and WormLab, have both been very well received and we look forward to making these even better in 2013.